Page last updated: 2024-08-18

isomethyleugenol and Thrombocytopenia

isomethyleugenol has been researched along with Thrombocytopenia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baba, R; Hara, R; Hibino, R; Hirakawa, T; Igaki, S; Ito, M; Iwasaki, S; Iwatani, M; Kamada, H; Kamada, Y; Kimura, H; Matsuda, S; Matsumiya, K; Morimoto, S; Oki, H; Toyofuku, M; Tsuchida, K1
Akria, L; Arad, A; Aviv, A; Braester, A; Dally, N; Filanovsky, K; Gafter-Gvili, A; Gatt, ME; Hellmann, I; Herishanu, Y; Herzog-Tzarfati, K; Leiba, R; Merkel, D; Mittelman, M; Nagler, A; Nemets, A; Ofran, Y; Ronson, A; Rouvio, O; Silbershatz, I; Tadmor, T; Vidal, L; Yeganeh, S1

Other Studies

2 other study(ies) available for isomethyleugenol and Thrombocytopenia

ArticleYear
T-448, a specific inhibitor of LSD1 enzyme activity, improves learning function without causing thrombocytopenia in mice.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2019, Volume: 44, Issue:8

    Topics: Animals; Benzamides; Brain; Cells, Cultured; Enzyme Inhibitors; Histone Demethylases; Histones; Humans; Male; Maze Learning; Methylation; Mice; Neurons; Primary Cell Culture; Proto-Oncogene Proteins; Rats; Repressor Proteins; Thrombocytopenia

2019
Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: a retrospective multicenter study.
    American journal of hematology, 2013, Volume: 88, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Chromosome Aberrations; Disease Susceptibility; Female; Humans; Incidence; Infections; Israel; Leukemia, Myeloid, Acute; Male; Methylation; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Retrospective Studies; Risk Factors; Severity of Illness Index; Thrombocytopenia

2013
chemdatabank.com